Barriers to and Facilitators of Diabetic Retinopathy Screening Utilization in a High-Risk Population

被引:34
|
作者
Fairless, Elizabeth [1 ]
Nwanyanwu, Kristen [2 ]
机构
[1] Yale Sch Med, 265 St John St, New Haven, CT 06511 USA
[2] Yale Sch Med, Dept Ophthalmol & Visual Sci, 40 Temple St, New Haven, CT 06510 USA
关键词
Diabetic retinopathy; Health disparities; Qualitative research; Diabetes; Diabetic eye screening; Ophthalmology; HEALTH-PROMOTION; UNITED-STATES; VISION CARE; ADHERENCE; TELEMEDICINE; DISPARITIES; GUIDELINES;
D O I
10.1007/s40615-019-00627-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Diabetic retinopathy (DR) is among the leading causes of vision loss in the USA, yet an estimated 50% of patients with diabetes do not receive recommended annual screening eye exams. Patients with diabetes and low socioeconomic status or who are racial/ethnic minorities are at increased risk for vision loss. Methods Qualitative interviews were conducted with 24 patients with diabetes at a federally qualified community health center in an urban area regarding factors influencing their use of screening. The interviews were recorded, transcribed, and analyzed line by line to identify themes. The themes were organized in a theoretical framework of factors influencing receipt of screening. Results The median age of participants was 57.5 (range 44-73). Ten participants identified as female and 14 as male. Participants identified as Black (14), White (4), Hispanic (3), and other/no answer (3). Twenty-three had health insurance. Twenty-three had received an eye exam within in the past year, and 17 reported that they receive eye exams at least yearly. Four hundred fifteen comments were analyzed, and 22 concepts were identified under 7 broader themes and two overarching categories of individual and structural factors. Themes included vision status, competing concerns, emotional context, resource availability, in-clinic experience, cues to action, and knowledge about diabetes. Conclusions The factors that influence diabetic retinopathy screening utilization are complex. Visual symptoms and the need for glasses are important facilitators of screening. Many patients lack knowledge about diabetic retinopathy and the utility of preventative eye care. New strategies for engaging high-risk populations are necessary.
引用
收藏
页码:1244 / 1249
页数:6
相关论文
共 50 条
  • [31] The performance of a diabetic retinopathy risk score for screening for diabetic retinopathy in Chinese overweight/obese patients with type 2 diabetes mellitus
    Wang, Jiao
    Chen, Hong
    Zhang, Hua
    Yang, Fan
    Chen, Rong-Ping
    Li, Yan-Bing
    Yang, Chuan
    Lin, Shao-Da
    Chen, Li-Shu
    Liang, Gan-Xiong
    Cai, De-Hong
    ANNALS OF MEDICINE, 2014, 46 (06) : 417 - 423
  • [32] Barriers to Prevention and Timely Presentation of Diabetic Foot Ulcers: Perspectives of Patients from a High-risk Urban Population in the United States
    Flattau, Anna
    Tanenbaum, Molly L.
    Gonzalez, Jeffrey S.
    Andrews, Cary
    Twomey, Stephanie
    Vileikyte, Loretta
    McKee, M. Diane
    JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2021, 32 (03) : 1554 - 1565
  • [33] A risk prediction tool for colorectal cancer screening: a qualitative study of patient and provider facilitators and barriers
    Matthias, Marianne S.
    Imperiale, Thomas F.
    BMC FAMILY PRACTICE, 2020, 21 (01)
  • [34] Panretinal photocoagulation versus intravitreal injection retreatment pain in high-risk proliferative diabetic retinopathy
    Farias de Araujo Lucena, Celia Regina
    Ramos Filho, Jose Afonso
    Vieira Messias, Andre Marcio
    da Silva, Jose Aparecido
    Paes de Almeida, Felipe Piacentini
    Scott, Ingrid Ursula
    Santana Ribeiro, Jefferson Augusto
    Jorge, Rodrigo
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2013, 76 (01) : 18 - 20
  • [35] Analgesic Effectiveness of Potassium Diclofenac for Retinal Photocoagulation in Patients With High-Risk Proliferative Diabetic Retinopathy
    Jorge, R.
    Rodrigues, A. F.
    Ribeiro, J. A. S.
    Da Silva, J. A.
    Scott, I. U.
    Messias, A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [36] Octreotide reduces vitreous hemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy
    Boehm, BO
    Lang, GK
    Jehle, PM
    Feldmann, B
    Lang, GE
    HORMONE AND METABOLIC RESEARCH, 2001, 33 (05) : 300 - 306
  • [37] Developing a Risk Stratification Model Based on Machine Learning for Targeted Screening of Diabetic Retinopathy in the Indian Population
    Surya, Janani
    Kashyap, Himanshu
    Nadig, Ramya R.
    Raman, Rajiv
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [38] Strategies of Digital Fundus Photography for Screening Diabetic Retinopathy in a Diabetic Population in Urban China
    Ding, Jiyuan
    Zou, Yanhong
    Liu, Ningpu
    Jiang, Li
    Ren, Xuetao
    Jia, Wei
    Snellingen, Torkel
    Chongsuvivatwong, Virasakdi
    Liu, Xipu
    OPHTHALMIC EPIDEMIOLOGY, 2012, 19 (06) : 414 - 419
  • [39] Eye Care Use Among a High-Risk Diabetic Population Seen in a Public Hospital's Clinics
    MacLennan, Paul A.
    McGwin, Gerald, Jr.
    Heckemeyer, Christine
    Lolley, Virginia R.
    Hullett, Sandral
    Saaddine, Jinan
    Shrestha, Sundar S.
    Owsley, Cynthia
    JAMA OPHTHALMOLOGY, 2014, 132 (02) : 162 - 167
  • [40] A Population-based Screening of Type 2 Diabetes in High-risk Population of Yasuj, Iran
    Safari, Mitra
    Yazdanpanah, Behrouz
    Yazdanpanah, Behzad
    Mobasheri, Ali
    JOURNAL OF HEALTH POPULATION AND NUTRITION, 2014, 32 (04) : 677 - 686